Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS: AMPE · Delayed Price · USD
0.496
+0.254 (104.99%)
Apr 19, 2024, 3:47 PM EDT - Market closed
Ampio Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.16 | 0.08 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | - | - | - | 1413.88% | 53.57% | Upgrade
|
| Cost of Revenue | 0 | 2.08 | 1.09 | 1.18 | 1.27 | 0.52 | 0.57 | 0.95 | 0.37 | 2.24 | Upgrade
|
| Gross Profit | 0 | -2.08 | -1.09 | -1.18 | -1.27 | -0.52 | -0.57 | -0.95 | 0.79 | -2.16 | Upgrade
|
| Selling, General & Admin | 7.08 | 11.47 | 8.67 | 6.65 | 5.9 | 4.36 | 5.14 | 6.54 | 15.14 | 12.23 | Upgrade
|
| Research & Development | 2.44 | 8.92 | 11.9 | 9.17 | 12.62 | 6.83 | 10.42 | 10.55 | 18.96 | 26.92 | Upgrade
|
| Other Operating Expenses | 0.06 | 1.94 | 0 | 0.01 | 0.06 | 0 | 0.32 | 0.14 | 0 | 0 | Upgrade
|
| Operating Expenses | 9.57 | 20.38 | 20.57 | 15.83 | 18.58 | 11.18 | 15.56 | 17.08 | 34.1 | 39.15 | Upgrade
|
| Operating Income | -8.63 | -24.21 | -25.16 | -15.22 | -23.45 | -11.18 | -15.56 | -17.08 | -33.3 | -39.07 | Upgrade
|
| Interest Income | 0.35 | 0.22 | 0 | 0.01 | 0.08 | -0.01 | 0 | 0.02 | -0.33 | 0.02 | Upgrade
|
| Interest Expense | 0 | -7.87 | 0 | 0 | 0.08 | -0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Expense / Income | 0.35 | 0.22 | -8.08 | 0.69 | -9.82 | -90.34 | 0 | 1.07 | -0.33 | - | Upgrade
|
| Pretax Income | -8.63 | -16.34 | -17.08 | -15.89 | -13.63 | 33.99 | -51.89 | -19.16 | -33.71 | -39.05 | Upgrade
|
| Income Tax | 0 | -7.87 | -4.59 | 0.6 | -4.95 | 45.17 | 36.33 | 1.04 | -1.29 | -0.92 | Upgrade
|
| Net Income | -8.63 | -8.47 | -12.49 | -16.5 | -8.68 | 33.99 | -51.89 | -19.16 | -32.01 | -38.13 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 4 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 4 | 0 | 0 | Upgrade
|
| Shares Change | 7.50% | 12.23% | 12.78% | 25.61% | 23.29% | -91.17% | 21.43% | 1968.52% | 3.52% | 31.16% | Upgrade
|
| EPS (Basic) | -10.66 | -11.24 | -18.79 | -28.63 | -18.32 | 88.39 | -11.92 | -5.35 | -186.00 | -228.00 | Upgrade
|
| EPS (Diluted) | -10.66 | -11.24 | -18.59 | -27.71 | -18.32 | 88.39 | -11.92 | -5.35 | -186.00 | -228.00 | Upgrade
|
| Free Cash Flow | -8.56 | -21.13 | -14.19 | -14.79 | -15.41 | -12.7 | -11.48 | -14.63 | -26.68 | -39.41 | Upgrade
|
| Free Cash Flow Per Share | -10.57 | -28.04 | -21.13 | -24.84 | -32.50 | -33.04 | -2.64 | -4.08 | -153.95 | -235.39 | Upgrade
|
| Gross Margin | - | - | - | - | - | - | - | - | 68.23% | -2818.46% | Upgrade
|
| Operating Margin | - | - | - | - | - | - | - | - | -2864.79% | -50882.57% | Upgrade
|
| Profit Margin | - | - | - | - | - | - | - | - | -2753.66% | -49650.87% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | - | - | - | -2295.11% | -51322.40% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 132.91% | - | - | - | - | Upgrade
|
| EBITDA | -8.63 | -23.16 | -24.06 | -14.04 | -22.17 | -55.08 | 21.98 | -14.81 | -32.09 | -38.63 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | - | - | - | -2760.35% | -50310.73% | Upgrade
|
| Depreciation & Amortization | 0.12 | 1.05 | 1.09 | 1.18 | 1.27 | 1.28 | 1.21 | 1.21 | 1.14 | 0.44 | Upgrade
|
| EBIT | -8.75 | -24.21 | -25.16 | -15.22 | -23.45 | -56.36 | 20.77 | -16.02 | -33.22 | -39.07 | Upgrade
|
| EBIT Margin | - | - | - | - | - | - | - | - | -2858.10% | -50882.57% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.